Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple System Atrophy (MSA)”

87 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 87 results

Early research (Phase 1)Looking for participantsNCT07289477
What this trial is testing

A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy

Who this might be right for
Multiple System Atrophy - Parkinsonian Subtype (MSA-P)
iRegene Therapeutics Co., Ltd. 9
Not applicableLooking for participantsNCT06920134
What this trial is testing

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease

Who this might be right for
Hypotension SymptomaticParkinson's DiseaseOrthostatic Hypotension, Dysautonomic+2 more
Ecole Polytechnique Fédérale de Lausanne 5
Early research (Phase 1)Active Not RecruitingNCT05698017
What this trial is testing

Study to Evaluate Investigational Allogeneic Cell Therapy Product hOMSC300 for Treatment of Early to Moderate Stage Multiple System Atrophy (MSA)

Who this might be right for
Multiple System AtrophyMSA - Multiple System Atrophy
Cytora Ltd. 10
Testing effectiveness (Phase 2)UnknownNCT00758849
What this trial is testing

Fipamezole in Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Parkinson's DiseaseMultiple System Atrophy
Juvantia Pharma Ltd 24
Testing effectiveness (Phase 2)Study completedNCT04184063
What this trial is testing

Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)

Who this might be right for
Progressive Supranuclear PalsyMultiple System Atrophy
EmeraMed 20
Not applicableStudy completedNCT06204575
What this trial is testing

Focused Ultrasound Thalamotomy for Tremor Relief in Atypical Parkinsonism

Who this might be right for
Atypical ParkinsonismDementia With Lewy BodiesMultiple System Atrophy, MSA
Rambam Health Care Campus 8
Not applicableLooking for participantsNCT07324330
What this trial is testing

Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity

Who this might be right for
Parkinson DiseaseProdromal StageNeurodegenerative Diseases+7 more
University Hospital, Bonn 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT02315027
What this trial is testing

Mesenchymal Stem Cell Therapy in Multiple System Atrophy

Who this might be right for
MSA
Mayo Clinic 30
Not applicableStudy completedNCT04229173
What this trial is testing

Natural History and Disease Progression Biomarkers of Multiple System Atrophy

Who this might be right for
Multiple System Atrophy
University Hospital, Toulouse 61
Very early researchLooking for participantsNCT06891703
What this trial is testing

[18F]ACI-15916 PET in α-synucleinopathies

Who this might be right for
Parkinson's Disease (PD)Multiple System Atrophy (MSA)Dementia With Lewy Bodies (DLB)
AC Immune SA 46
Testing effectiveness (Phase 2)Study completedNCT02705755
What this trial is testing

TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

Who this might be right for
Neurogenic Orthostatic HypotensionMultiple System Atrophy (MSA) With Orthostatic HypotensionPure Autonomic Failure+5 more
Theravance Biopharma 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT05923866
What this trial is testing

ONO-2808 in Patients With Multiple System Atrophy

Who this might be right for
Multiple System Atrophy (MSA)
Ono Pharmaceutical Co., Ltd. 92
Early research (Phase 1)Study completedNCT02270489
What this trial is testing

Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA

Who this might be right for
Multiple System AtrophyNeurodegenerative Diseases
Affiris AG 30
Testing effectiveness (Phase 2)Study completedNCT00977665
What this trial is testing

Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)

Who this might be right for
Multiple System Atrophy
Teva Branded Pharmaceutical Products R&D, Inc. 174
Not applicableStudy completedNCT05011773
What this trial is testing

Manipulating and Optimising Brain Rhythms for Enhancement of Sleep

Who this might be right for
Parkinson DiseaseMSA - Multiple System AtrophyChronic Pain+1 more
University of Oxford 4
Large-scale testing (Phase 3)Active Not RecruitingNCT06706622
What this trial is testing

A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA)

Who this might be right for
Multiple System Atrophy
H. Lundbeck A/S 357
Testing effectiveness (Phase 2)Looking for participantsNCT06868628
What this trial is testing

A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)

Who this might be right for
Multiple System Atrophy
Tiziana Life Sciences LTD 5
Not applicableLooking for participantsNCT06647641
What this trial is testing

The CurePSP Genetics Program

Who this might be right for
PSPPSP - Progressive Supranuclear PalsyCorticobasal Syndrome+17 more
Massachusetts General Hospital 1,000
Not applicableStudy completedNCT01044992
What this trial is testing

Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study

Who this might be right for
Multisystemic Atrophy
University Hospital, Toulouse 38
Testing effectiveness (Phase 2)Study completedNCT02388295
What this trial is testing

AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients

Who this might be right for
Multiple System Atrophy, MSA
AstraZeneca 59
Load More Results